Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Tofacitinib (Primary)
- Indications Alopecia; Alopecia areata
- Focus Therapeutic Use
- 16 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 16 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.